coldsnowstorm / istock

Coronavirus Roundup: EPA Watchdog to Review Workplace Safety Measures; White House Is Rethinking Federal Vaccine Strategy

Here’s today’s list of news updates and stories you may have missed.

The pandemic, “does not appear to have significantly transformed the size or composition of the federal workforce,” in the short-term, according to an analysis by the nonprofit Partnership for Public Service released on Friday. For example, among the front-line agencies, from March to December 2020, “the full-time workforces across these six agencies grew by an average of 0.7% per quarter, just slightly outpacing the 0.6% in average growth seen governmentwide over the same period,” said the report. The Federal Emergency Management Agency “saw the largest expansion, averaging 1.3% per quarter, while the [National Institutes of Health] workforce retracted by 2.7% on average.” Here are some of the other recent headlines you might have missed. 

There are now 25 federally run vaccination sites across the country following the addition of new sites in Boston, Norfolk, Va., and Newark, N.J., the White House coronavirus response team announced on Friday. Overall, there are nearly 50,000 locations nationwide where people can get vaccinated, said Jeff Zients, White House coronavirus response coordinator. Last week, President Biden increased the goal of administering 100 million shots in his first 100 days in office (which ends April 30) to 200 million shots. 

Despite the addition of new federal vaccination sites, the administration is rethinking its vaccine strategy since “the existing system of government-run mass vaccination pilot sites has been costly,” Politico reported on Monday. “The sites have administered just 1.7 million doses since the beginning of February and about 67,000 shots a day over the last two weeks, per internal FEMA briefing documents and data obtained by Politico. That’s roughly 2.5% of all doses administered nationwide during the same period, according to data published by the CDC.”

Army Lt. Gen. Ronald J. Place, director of the Defense Health Agency, said on Friday that the entire Defense Department could be vaccinated by the middle of July. So far, more than 600,000 service members from the department’s three components have received at least their first does, he said.

The administration is working with private companies to develop a standard for “vaccine passports,” The Washington Post reported on Sunday. Many companies and businesses said this will be a requirement for returning to normal operations, however, there are lingering concerns over the ethics of such passports. “If it became a government mandate, it would go down a dark road very quickly,” Brian Castrucci, head of the de Beaumont Foundation, a public health group that is funding research in to why some Americans are hesitant about the vaccine, told the paper. “It becomes a credential. It becomes a ‘needing your papers,’ if you will. That could be dangerous—and it could turn off people.”

FEMA officials said the District of Columbia will not get a mass vaccination site, despite its “high social vulnerability” status (calculated based on race and poverty levels) due to its population size, The Washington Post reported. “FEMA has also rejected requests from the District and the governors of Maryland and Virginia to help vaccinate the massive essential federal workforce in the capital region, including transit workers and postal workers,” the report noted. 

Some former top health officials in the Trump administration are coordinating how they will talk about the COVID response under Trump out of fear they will be “scapegoated” by other colleagues, such as former Health and Human Services Secretary Alex Azar, Politico reported last week. The group includes the former Food and Drug Administration commissioner, Centers for Disease Control and Prevention director, Medicare chief and White House COVID-19 coordinator, many of whom sparred with Azar. “The behind-the-scenes efforts represent just one part of the broader race to shape the story around the Trump administration’s response to the health crisis, which was marked by constant internal conflict,” said the report. “The turbulent period will be the subject of numerous forthcoming books and television specials, with little expectation the previous administration will be vindicated in those accounts.” 

The Justice Department announced on Friday that since the start of the pandemic it has charged 474 defendants in coronavirus fraud schemes that involved attempts to obtain over $569 million from the federal government. At least 120 of the defendants tried to scam the Small Business Administration's Paycheck Protection Program. This has been a “historic enforcement initiative” said Attorney General Merrick Garland in a statement. “The impact of the department’s work to date sends a clear and unmistakable message to those who would exploit a national emergency to steal taxpayer-funded resources from vulnerable individuals and small businesses.”

Newly confirmed Labor Secretary Marty Walsh is getting involved in the Occupational Safety and Health Administration’s stalled decision over whether or not it will issue an emergency temporary standard for the coronavirus, Bloomberg reported on Friday. In an executive order issued on day two of his administration, President Biden directed the agency to make a decision by March 15. Although the agency has taken several actions since then to bolster its coronavirus response, it has not specifically said anything about the standards yet.

The Environmental Protection Agency inspector general released its fiscal 2021 oversight plan on Friday, which includes reviewing if the agency followed health and safety protocols upon employees return to workplaces. Other planned and ongoing reviews involve how the pandemic impacted EPA’s ability to carry out its missions. The return to offices has been a source of tension between the agency and its union.

At a briefing on Friday, White House Press Secretary Jen Psaki said the president “certainly wants to have an FDA commissioner in place” and “wants it to be the right person.” Former FDA officials from Republican and Democratic administrations have been calling on the president to name someone, saying the pandemic presents an urgent need for a confirmed leader.

CDC Director Dr. Rochelle Walensky said this morning she feels an “impending doom” over the rise of coronavirus cases, hospitalizations and deaths over the last week. She pleaded that everyone should do what they can to prevent a fourth surge. “When I first started at CDC about two months ago I made a promise to you: I would tell you the truth even if it was not the news we wanted to hear,” she said. “Now is one of those times when I have to share the truth and I have to hope and trust you will listen.” 

Later on Monday, President Biden will provide an update on the pandemic response and vaccinations at 2:10 p.m.

Help us understand the situation better. Are you a federal employee, contractor or military member with information, concerns, etc. about how your agency is handling the coronavirus? Email us at newstips@govexec.com.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.